
Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …

Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …

Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …

The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …
Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …

Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …

As many as 14,000 patients may have been exposed to contaminated steriods that have led to 23 deaths due to …

Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …

Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …
Management Forum has teamed up with NSF-DBA, experts in medical device professional training, to bring certification programmes aimed at demonstrating …

The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …
Extensive project management expertise and logistical control know-how are obviously required when working on a combination product from the concept …
Dr Christoph Schnorr has joined Quintiles as head of its European Research and Development consulting practice. Schnorr joins quintiles from Merck …

The ABPI has seized on two reports – one its own and one independent – published this week to assert …
Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …

Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …